A new report by the Access to Medicine Foundation reveals that efforts to combat antimicrobial resistance (AMR) are lagging, with a 35% decrease in drug development over five years. The report highlights the urgent need for new antibiotics, especially for vulnerable populations in low-income countries. It notes that AMR causes over 35,000 deaths annually in the EU and projects 39 million deaths worldwide by 2050. The report identifies a lack of pediatric drugs and calls for significant reforms in the industry to address the AMR crisis.